Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines

International Journal of Oncology

Volumn 29, Issue 3, 2006, Pages 655-663

  Guan, Na ^a   Korukonda, Rajani ^b   Hurh, Eunju ^a   Schmittgen, Thomas D ^a   Donkor, Isaac O ^b   Dalton, James T ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Apoptosis; Calpain; Cell cycle

Indexed keywords

ALDEHYDE; CALPAIN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CYSTEINE PROTEINASE INHIBITOR; PROTEASOME;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HELA CELL; HUMAN; LEUKEMIA CELL LINE; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ALDEHYDES; APOPTOSIS; CALPAIN; CASPASE 3; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; G2 PHASE; HELA CELLS; HUMANS; JURKAT CELLS; MALE; PROSTATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 33749363042     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.3.655     Document Type: Article

References (36)

1. An WG, Hwang SG, Trepel JB and Blagosklonny MV: Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 14: 1276-1283, 2000.
2. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ: Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59: 2615-2622, 1999. (Pubitemid 29269108)
3. O'Connor OA: The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas. Curr Treat Options Oncol 5: 269-281, 2004.
4. Kishimoto A, Kajikawa N, Shiota M and Nishizuka Y: Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem 258: 1156-1164, 1983.
5. Frangioni JV, Oda A, Smith M, Salzman EW and Neel BG: Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 12: 4843-4856, 1993. (Pubitemid 23330291)
6. Altznauer F, Conus S, Cavalli A, Folkers G and Simon HU: Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279: 5947-5957, 2004. (Pubitemid 38220627)
7. Watanabe N, Vande Woude GF, Ikawa Y and Sagata N: Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature 342: 505-511, 1989.
8. Nixon RA: Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons. J Neurosci 6: 1264-1271, 1986.
9. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR and Siman R: Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14: 3934-3944, 1994.
10. Hirai S, Kawasaki H, Yaniv M and Suzuki K: Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett 287: 57-61, 1991.
11. Han Y, Weinman S, Boldogh I, Walker RK and Brasier AR: Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem 274: 787-794, 1999. (Pubitemid 129535237)
12. Lu Q and Mellgren RL: Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells. Arch Biochem Biophys 334: 175-181, 1996. (Pubitemid 26329815)
13. Zhu DM and Uckun FM: Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells. Clin Cancer Res 6: 2456-2463, 2000.
14. Zhu W, Murtha PE and Young CY: Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 214: 1130-1137, 1995.
15. Atencio IA, Ramachandra M, Shabram P and Demers GW: Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ 11: 247-253, 2000. (Pubitemid 30347204)
16. Satish L, Blair HC, Glading A and Wells A: Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol Cell Biol 25: 1922-1941, 2005.
17. Carragher NO and Frame MC: Calpain: a role in cell transformation and migration. Int J Biochem Cell Biol 34: 1539-1543, 2002.
18. Li G and Iyengar R: Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta-catenin-regulated cell proliferation. Proc Natl Acad Sci USA 99: 13254-13259, 2002.
19. Xu Y and Mellgren RL: Calpain inhibition decreases the growth rate of mammalian cell colonies. J Biol Chem 277: 21474-21479, 2002. (Pubitemid 34952290)
20. Rios-Doria J, Kuefer R, Ethier SP and Day ML: Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res 64: 7237-7240, 2004. (Pubitemid 39372058)
21. Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC and Sharma RK: Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev 13: 1604-1609, 2004. (Pubitemid 39331881)
22. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H and Kawashima S: Apoptosis induction resulting from proteasome inhibition. Biochem J 317: 385-388, 1996. (Pubitemid 26253972)
23. Squier MK, Miller AC, Malkinson AM and Cohen JJ: Calpain activation in apoptosis. J Cell Physiol 159: 229-237, 1994.
24. Donkor IO, Korukonda R, Huang TL and LeCour L Jr: Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics. Bioorg Med Chem Lett 13: 783-784, 2003. (Pubitemid 36255537)
25. Schmittgen TD: Real-time quantitative PCR. Methods 25: 383-385, 2001.
26. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W and Kalden JR: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22: 5506-5507, 1994.
27. Stein RL, Melandri F and Dick L: Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry 35: 3899-3908, 1996. (Pubitemid 26113443)
28. Adachi Y, Kitahara-Ozawa A, Sugamura K, Lee WJ, Yodoi J, Maki M, Murachi T and Hatanaka M: Expression of calpain II gene in human hematopoietic system cells infected with human T-cell leukemia virus type I. J Biol Chem 267: 19373-19378, 1992.
29. Farkas A, Tompa P and Friedrich P: Revisiting ubiquity and tissue specificity of human calpains. Biol Chem 384: 945-949, 2003. (Pubitemid 36874509)
30. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA and Trepel JB: Regulation of cyclin D1 by calpain protease. J Biol Chem 272: 28479-28484, 1997.
31. Kubbutat MH and Vousden KH: Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 17: 460-468, 1997.
32. Janossy J, Ubezio P, Apati A, Magocsi M, Tompa P and Friedrich P: Calpain as a multi-site regulator of cell cycle. Biochem Pharmacol 67: 1513-1521, 2004. (Pubitemid 38388213)
33. Schollmeyer JE: Calpain II involvement in mitosis. Science 240: 911-913, 1988.
34. Patel YM and Lane MD: Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J Biol Chem 275: 17653-17660, 2000.
35. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998.
36. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M and Okamoto T: Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem 276: 42971-42977, 2001.